loading page

Modeling the Tumor Microenvironment In Vitro in Prostate Cancer: Current And Future Perspectives
  • +2
  • Kedi Yuan,
  • Xinxing Du,
  • Liang Dong,
  • Jiahua Pan,
  • Wei Xue
Kedi Yuan
Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital
Author Profile
Xinxing Du
Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital Department of Urology
Author Profile
Liang Dong
Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital Department of Urology
Author Profile
Jiahua Pan
Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital Department of Urology
Author Profile
Wei Xue
Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital Department of Urology

Corresponding Author:[email protected]

Author Profile

Abstract

Prostate cancer is the most common cancer in over 50% of the countries and the third most common malignancy worldwide. The tumor microenvironment denotes the non-cancerous cells and components present in the tumor, including the molecules they produce and release. Prostate cancer proliferation, angiogenesis, metastasis and drug resistance are closely associated with the tumor microenvironment. With the continuous development of in vitro tumor models, they have gradually become an important tool for recapitulating parental tumors in vivo and studying the reciprocal interactions between tumors and their microenvironment. In this review, we describe significant in vitro models of prostate cancer, analyze the research results on incorporating the tumor microenvironment into these models, and compare their advantages and disadvantages. Furthermore, we highlight the future developmental direction of prostate cancer in vitro model research according to the hotspots of in vitro model research in other cancer types to facilitate precision medicine in prostate cancer.
12 Aug 2024Submitted to View
13 Aug 2024Submission Checks Completed
13 Aug 2024Assigned to Editor
13 Aug 2024Review(s) Completed, Editorial Evaluation Pending
30 Aug 2024Reviewer(s) Assigned
06 Sep 2024Editorial Decision: Revise Minor
07 Sep 20241st Revision Received
09 Sep 2024Submission Checks Completed
09 Sep 2024Assigned to Editor
09 Sep 2024Review(s) Completed, Editorial Evaluation Pending
10 Sep 2024Editorial Decision: Accept